Ettrich TJ, Perkhofer L, Decker T, Hofheinz RD, et al. Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: the randomized, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111). Int J Cancer 2020 Sep 15. doi: 10.1002/ijc.33296.
PMID: 32930387